Apex Biotechnology Corp (1733) — Long-term Investment Intensity
Apex Biotechnology Corp (1733) has a Long-term Investment Intensity of 0.2% as of December 2019. Long-term investments of NT$6.20 Million represent 0.2% of total assets of NT$2.81 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Apex Biotechnology Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Apex Biotechnology Corp Long-term Investment Intensity (2013–2019)
This chart shows how Apex Biotechnology Corp's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.2%, reflecting long-term investments of NT$6.20 Million against total assets of NT$2.81 Billion TWD. Explore 1733 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Apex Biotechnology Corp (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Apex Biotechnology Corp from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 1733 market cap overview.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.2% | NT$6.20 Million | NT$2.81 Billion | ▲ +0.2 pp |
| 2018 | 0.0% | NT$40.00K | NT$2.55 Billion | ▼ -0.5 pp |
| 2017 | 0.5% | NT$14.13 Million | NT$2.70 Billion | ▼ -0.6 pp |
| 2016 | 1.1% | NT$27.35 Million | NT$2.50 Billion | ▼ -5.8 pp |
| 2015 | 6.9% | NT$187.03 Million | NT$2.69 Billion | ▼ -0.5 pp |
| 2014 | 7.4% | NT$197.03 Million | NT$2.64 Billion | ▲ +0.2 pp |
| 2013 | 7.2% | NT$197.03 Million | NT$2.72 Billion | — |